Article
Epigenetic pathways and glioblastoma treatment
23 Jul 2013
Abstract excerpt
Glioblastoma multiforme (GBM) is the most common malignant adult brain tumor. Standard GBM treatment includes maximal safe surgical resection with combination radiotherapy and adjuvant temozolomide (TMZ) chemotherapy. Alarmingly, patient survival at five-years is below 10%. This is in part due to the invasive behavior of the tumor and the resulting inability to resect greater than 98% of some tumors. In fact,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
